| Pharmacokinetics and safety evaluation in healthy Chinese volunteers of alkaloids from leaf of Alstonia scholaris: A multiple doses phase I clinical trial | |
Li, Rui1; Zi, Ming-Jie1; Gou, Zhong-Ping4; Zhao, Yun-Li2; Zhang, Wan-Tong1; Lu, Fang1; Cao, Wei-Yi1; Zhao, Ying-Pan1; Li, Qing-Na1; Zhao, Yang1; Wang, Shu-Ge1; Gao, Hong-Yang1; Sun, Ming-Yue1; Luo, Xiao-Dong2 ; Xiong, Zhi-Li3; Gao, Rui1
| |
| Corresponding Author | Luo, Xiao-Dong(xdluo@mail.kib.ac.cn) ; Xiong, Zhi-Li(bearry200@126.com) ; Gao, Rui(Ruigao@126.com) |
| 2019-08-01 | |
| Source Publication | PHYTOMEDICINE
 |
| ISSN | 0944-7113 |
| Volume | 61Pages:13 |
| Abstract | Background: Alstonia scholaris (Apocynaceae) was reported to be a rich source of indole alkaloids, which exhibited remarkably bioactivities. The leaf of A. scholaris has been used in 'dai' ethno-medicine for treatment of respiratory diseases, and the defined indole alkaloids from leaf of A. scholaris has been registered as investigational new botanical drug (No. 2011L01436) and was approved for phase I/II clinical trials by China Food and Drug Administration (CFDA). Purpose: The aim of the trial is to evaluate the safety and explore the relationship of dosing frequency and pharmacokinetics after oral administration of capsule of alkaloids from leaf of A. scholaris (CALAS) at different doses. Methods: In this randomized, open-labelled, single-center clinical trial, the safety and pharmacokinetics of CALAS were assessed in eligible healthy Chinese volunteers after oral administration of different doses. Each volunteer (n = 10 per group) received single dose of CALAS from 20 mg, 40 mg, 80 mg to 120 mg orally. The pharmacokinetics of CALAS was investigated in healthy Chinese subjects' plasma by a fully-validated LC-MS/MS method. Safety was assessed biochemically and clinically throughout the study, and drug re-excitation research was conducted to verify the correlation between investigational product and minor adverse events. The trial was registered on August 26, 2015 (http://www.chictr. org.cn/showproj.aspx?proj = 11736), number ChiCTR-IPR-15006976. Results: 40 subjects completed the study, and as a result, vallesamine had the highest concentration in plasma of healthy volunteers, and the AUC exposure level in each compounds in turn is vallesamine > scholaricine > 19-epischolaricine > picrinine. For the safety evaluation of CALAS, two cases of minor adverse events were observed during the trial, but the drug re-excitation research indicated that these two adverse events were related to the individual's physiological variation. Conclusion: Pharmacokinetic characteristics of each ingredient showed different patterns. 19-epischolaricine, vallesamine and picrinine were match to the linear pharmacokinetic characteristics, but scholaricine conformed to the characteristics of nonlinear pharmacokinetics. The CALAS was safe in healthy subjects under the current dose regimen. |
| Keyword | Capsule of alkaloids from leaf of A. scholaris (CALAS) Pharmacokinetics Safety evaluation Drug re-excitation research |
| DOI | 10.1016/j.phymed.2019.152828 |
| Indexed By | SCI ; SCI |
| Language | 英语 |
| WOS Research Area | Plant Sciences ; Pharmacology & Pharmacy ; Integrative & Complementary Medicine |
| WOS Subject | Plant Sciences ; Chemistry, Medicinal ; Integrative & Complementary Medicine ; Pharmacology & Pharmacy |
| WOS ID | WOS:000492729600027 |
| Citation statistics | |
| Document Type | 期刊论文 |
| Identifier | http://ir.kib.ac.cn/handle/151853/70197 |
| Collection | 植物化学与西部植物资源持续利用国家重点实验室 |
| Corresponding Author | Luo, Xiao-Dong; Xiong, Zhi-Li; Gao, Rui |
| Affiliation | 1.Chinese Med Sci, China Acad, Clin Pharmacol Inst, Xiyuan Hosp, Beijing 100091, Peoples R China 2.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China 3.Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Liaoning, Peoples R China 4.Sichuan Univ, West China Hosp, Inst Drug Clin Trials, Chengdu 610041, Sichuan, Peoples R China |
| Recommended Citation GB/T 7714 | Li, Rui,Zi, Ming-Jie,Gou, Zhong-Ping,et al. Pharmacokinetics and safety evaluation in healthy Chinese volunteers of alkaloids from leaf of Alstonia scholaris: A multiple doses phase I clinical trial[J]. PHYTOMEDICINE,2019,61:13. |
| APA | Li, Rui.,Zi, Ming-Jie.,Gou, Zhong-Ping.,Zhao, Yun-Li.,Zhang, Wan-Tong.,...&Gao, Rui.(2019).Pharmacokinetics and safety evaluation in healthy Chinese volunteers of alkaloids from leaf of Alstonia scholaris: A multiple doses phase I clinical trial.PHYTOMEDICINE,61,13. |
| MLA | Li, Rui,et al."Pharmacokinetics and safety evaluation in healthy Chinese volunteers of alkaloids from leaf of Alstonia scholaris: A multiple doses phase I clinical trial".PHYTOMEDICINE 61(2019):13. |
| Files in This Item: | Download All | |||||
| File Name/Size | DocType | Version | Access | License | ||
| Li-2019-Pharmacokine（3744KB） | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | View Download | |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment